Global ADVENT FORUM 2023, Dermatology Section | Madrid
New expert presentations from the 2023 ADVENT FORUM, Dermatology section, where the global faculty discuss itch as the common thread in dermatological type 2 inflammation, the evolving concept of disease modification in atopic dermatitis, and the latest updates in prurigo nodularis and chronic spontaneous urticaria.
Learning objectives
- Discuss the pathophysiological processes mediating pruritus in AD, PN, and CSU
- Describe how type 2 inflammatory cytokines are involved in inducing and amplifying pruritus in AD, PN, and CSU
- Explore the shared and distinct mechanisms of pruritus in AD, PN, and CSU
- Explore the concept of disease modification in the context of AD
- Review existing data on disease control with therapeutic interventions and discuss the markers that could be used to define deep remission in AD
- Discuss perspectives for reducing the development of new or worsening future atopic comorbidities
- Describe the wide-ranging disease burden of PN and CSU, and discuss how this impacts patient quality of life and treatment needs
- Review current unmet needs in PN and CSU management
- Describe the evolving therapeutic landscape in PN and CSU, considering data for approved treatments and ongoing clinical trials, and discuss potential impacts on patient management in the respective therapeutic areas
Description
Itch: The Common Thread in Dermatological Type 2 Inflammation (AD, PN, and CSU)
In the ADVENT Event at the 2023 ADVENT FORUM, Drs. Stephan Weidinger, Eric Simpson, Raj Chovatiya, and Thomas Casale discussed the shared and unique neuroimmune mechanisms and supporting data demonstrating the generation of itch across AD, PN, and CSU.
New Perspectives on Disease Modification in Atopic Dermatitis
In the ADVENT Event at the 2023 ADVENT FORUM, Dr. Michele Ramien, Dr. Eric Simpson, and Dr. Amy Paller explored the concept and potential of disease modification through therapeutic interventions in AD.
Updates in PN and CSU: Emerging Therapeutic Landscapes and Implications for Patient Management
In the ADVENT Event at the 2023 ADVENT FORUM, Drs. Raj Chovatiya, and Thomas B. Casale reviewed the wide-ranging burden and unmet needs in PN and CSU, presented trial data for approved and emerging therapies, and discussed the implications of the evolving therapeutic landscape for patient management in both therapeutic areas.
Location
Speakers
Related resources
